Multicentre, open-label study using imiquimod 5% cream in one or two 4-week courses of treatment for multiple actinic keratoses on the head

British Journal of Dermatology

Volumn 157, Issue SUPPL. 2, 2007, Pages 41-46

  Stockfleth, E ^a   Sterry, W ^a   Carey Yard, M ^b   Bichel, J ^b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b 3M Deutschland GmbH   (Germany)

Author keywords

Actinic keratosis; Clearance; Course of treatment; Field cancerisation; Imiquimod

Indexed keywords

IMIQUIMOD;

ACTINIC KERATOSIS; ADULT; AGED; ANOREXIA; APPLICATION SITE BURNING; APPLICATION SITE PAIN; APPLICATION SITE PRURITUS; APPLICATION SITE REACTION; ARTICLE; ASTHENIA; CLINICAL PRACTICE; CLINICAL TRIAL; CONTROLLED STUDY; CREAM; CUTANEOUS PARAMETERS; DIARRHEA; DIZZINESS; DRUG EFFICACY; DRUG FEVER; DRUG INDUCED HEADACHE; DRY SKIN; EDEMA; ERYTHEMA; EXUDATE; FATIGUE; FEMALE; FLU LIKE SYNDROME; GASTROENTERITIS; HEAD; HUMAN; LIMB PAIN; LOCAL SKIN REACTION; LOWER EYELID; LYMPHADENOPATHY; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; MYALGIA; NOSE CARTILAGE; OPEN STUDY; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; SKIN ULCER; TREATMENT DURATION; UPPER EYELID;

ADMINISTRATION, CUTANEOUS; AGED; AMINOQUINOLINES; ANTINEOPLASTIC AGENTS; CARCINOMA, SQUAMOUS CELL; DRUG ADMINISTRATION SCHEDULE; FACIAL NEOPLASMS; FEMALE; HUMANS; KERATOSIS; MALE; MIDDLE AGED; NEOPLASMS, RADIATION-INDUCED; PATIENT COMPLIANCE; SKIN NEOPLASMS; TREATMENT OUTCOME; ULTRAVIOLET RAYS;

EID: 36549032062     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2007.08272.x     Document Type: Article

References (6)

1. Lebwohl M, Dinehart S, Whiting D et al. Imiquimod 5% cream for the treatment of actinic keratosis: results from two phase III, randomized, double-blind, parallel group, vehicle-controlled trials. J Am Acad Dermatol 2004 50:714 21.
2. Korman N, Moy R, Ling M et al. Dosing with 5% imiquimod cream 3 times per week for the treatment of actinic keratosis. Arch Dermatol 2005 141:467 73.
3. Lee P, Harwell W, Loven K et al. Long term clinical outcomes following treatment of actinic keratosis with imiquimod 5% cream. Dermatol Surg 2005 31:659 64.
4. Szeimies R, Gerritsen M, Gupta G et al. Imiquimod 5% cream for the treatment of actinic keratosis: results from a phase III, randomized, double-blind, vehicle-controlled clinical trial with histology. J Am Acad Dermatol 2004 51:547 55.
5. Salasche SJ, Levine N, Morrison L. Cycle therapy of actinic keratoses of the face and scalp with 5% topical imiquimod cream: an open label trial. J Am Acad Dermatol 2002 47:571 77.
6. Wheeland R. The pitfalls of treating all actinic keratoses as squamous cell carcinomas. Semin Cutan Med Surg 2005 24:152 54.